152 related articles for article (PubMed ID: 30893604)
1. DBC1 Regulates p53 Stability via Inhibition of CBP-Dependent p53 Polyubiquitination.
Akande OE; Damle PK; Pop M; Sherman NE; Szomju BB; Litovchick LV; Grossman SR
Cell Rep; 2019 Mar; 26(12):3323-3335.e4. PubMed ID: 30893604
[TBL] [Abstract][Full Text] [Related]
2. DBC1 functions as a tumor suppressor by regulating p53 stability.
Qin B; Minter-Dykhouse K; Yu J; Zhang J; Liu T; Zhang H; Lee S; Kim J; Wang L; Lou Z
Cell Rep; 2015 Mar; 10(8):1324-34. PubMed ID: 25732823
[TBL] [Abstract][Full Text] [Related]
3. Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage.
Park JH; Lee SW; Yang SW; Yoo HM; Park JM; Seong MW; Ka SH; Oh KH; Jeon YJ; Chung CH
Nat Commun; 2014 Nov; 5():5483. PubMed ID: 25406032
[TBL] [Abstract][Full Text] [Related]
4. CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53.
Shi D; Pop MS; Kulikov R; Love IM; Kung AL; Grossman SR
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16275-80. PubMed ID: 19805293
[TBL] [Abstract][Full Text] [Related]
5. Dephosphorylation of DBC1 by Protein Phosphatase 4 Is Important for p53-Mediated Cellular Functions.
Lee J; Adelmant G; Marto JA; Lee DH
Mol Cells; 2015 Aug; 38(8):697-704. PubMed ID: 26194823
[TBL] [Abstract][Full Text] [Related]
6. A novel PTEN/mutant p53/c-Myc/Bcl-XL axis mediates context-dependent oncogenic effects of PTEN with implications for cancer prognosis and therapy.
Huang X; Zhang Y; Tang Y; Butler N; Kim J; Guessous F; Schiff D; Mandell J; Abounader R
Neoplasia; 2013 Aug; 15(8):952-65. PubMed ID: 23908595
[TBL] [Abstract][Full Text] [Related]
7. The WTX tumor suppressor enhances p53 acetylation by CBP/p300.
Kim WJ; Rivera MN; Coffman EJ; Haber DA
Mol Cell; 2012 Mar; 45(5):587-97. PubMed ID: 22285752
[TBL] [Abstract][Full Text] [Related]
8. Repression of estrogen receptor beta function by putative tumor suppressor DBC1.
Koyama S; Wada-Hiraike O; Nakagawa S; Tanikawa M; Hiraike H; Miyamoto Y; Sone K; Oda K; Fukuhara H; Nakagawa K; Kato S; Yano T; Taketani Y
Biochem Biophys Res Commun; 2010 Feb; 392(3):357-62. PubMed ID: 20074560
[TBL] [Abstract][Full Text] [Related]
9. MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm.
Pangon L; Mladenova D; Watkins L; Van Kralingen C; Currey N; Al-Sohaily S; Lecine P; Borg JP; Kohonen-Corish MR
Int J Cancer; 2015 Jan; 136(1):55-64. PubMed ID: 24824780
[TBL] [Abstract][Full Text] [Related]
10. Identification of DBC1 as a transcriptional repressor for BRCA1.
Hiraike H; Wada-Hiraike O; Nakagawa S; Koyama S; Miyamoto Y; Sone K; Tanikawa M; Tsuruga T; Nagasaka K; Matsumoto Y; Oda K; Shoji K; Fukuhara H; Saji S; Nakagawa K; Kato S; Yano T; Taketani Y
Br J Cancer; 2010 Mar; 102(6):1061-7. PubMed ID: 20160719
[TBL] [Abstract][Full Text] [Related]
11. SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1.
Zhang H; Xu Y; Filipovic A; Lit LC; Koo CY; Stebbing J; Giamas G
Br J Cancer; 2013 Nov; 109(10):2675-84. PubMed ID: 24129246
[TBL] [Abstract][Full Text] [Related]
12. SUMO1-regulated DBC1 promotes p53-dependent stress-induced apoptosis of lens epithelial cells.
Wang Y; Wang JM; Xiao Y; Hu XB; Zheng SY; Fu JL; Zhang L; Gan YW; Liang XM; Li DW
Aging (Albany NY); 2023 Sep; 15(17):8812-8832. PubMed ID: 37683133
[TBL] [Abstract][Full Text] [Related]
13. DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.
Zannini L; Buscemi G; Kim JE; Fontanella E; Delia D
J Mol Cell Biol; 2012 Oct; 4(5):294-303. PubMed ID: 22735644
[TBL] [Abstract][Full Text] [Related]
14. UNC119 is a binding partner of tumor suppressor Ras-association domain family 6 and induces apoptosis and cell cycle arrest by MDM2 and p53.
Iwasa H; Sarkar A; Shimizu T; Sawada T; Hossain S; Xu X; Maruyama J; Arimoto-Matsuzaki K; Withanage K; Nakagawa K; Kurihara H; Kuroyanagi H; Hata Y
Cancer Sci; 2018 Sep; 109(9):2767-2780. PubMed ID: 29931788
[TBL] [Abstract][Full Text] [Related]
15. Chk2 and REGγ-dependent DBC1 regulation in DNA damage induced apoptosis.
Magni M; Ruscica V; Buscemi G; Kim JE; Nachimuthu BT; Fontanella E; Delia D; Zannini L
Nucleic Acids Res; 2014 Dec; 42(21):13150-60. PubMed ID: 25361978
[TBL] [Abstract][Full Text] [Related]
16. p53 β-hydroxybutyrylation attenuates p53 activity.
Liu K; Li F; Sun Q; Lin N; Han H; You K; Tian F; Mao Z; Li T; Tong T; Geng M; Zhao Y; Gu W; Zhao W
Cell Death Dis; 2019 Mar; 10(3):243. PubMed ID: 30858356
[TBL] [Abstract][Full Text] [Related]
17. Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients.
Noh SJ; Kang MJ; Kim KM; Bae JS; Park HS; Moon WS; Chung MJ; Lee H; Lee DG; Jang KY
Pathology; 2013 Oct; 45(6):574-80. PubMed ID: 24018803
[TBL] [Abstract][Full Text] [Related]
18. NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2.
Liu X; Tan Y; Zhang C; Zhang Y; Zhang L; Ren P; Deng H; Luo J; Ke Y; Du X
EMBO Rep; 2016 Mar; 17(3):349-66. PubMed ID: 26882543
[TBL] [Abstract][Full Text] [Related]
19. Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53.
Schuldner M; Dörsam B; Shatnyeva O; Reiners KS; Kubarenko A; Hansen HP; Finkernagel F; Roth K; Theurich S; Nist A; Stiewe T; Paschen A; Knittel G; Reinhardt HC; Müller R; Hallek M; von Strandmann EP
Theranostics; 2019; 9(21):6047-6062. PubMed ID: 31534536
[TBL] [Abstract][Full Text] [Related]
20. Regulation of p53 by Mdm2: fate is in the numbers.
Shmueli A; Oren M
Mol Cell; 2004 Jan; 13(1):4-5. PubMed ID: 14731389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
